Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemerin, hypertension, and the imperative of sex-based analysis: lessons from Wabel et al.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Endothelial Dysfunction in Vascular Inflammation: The Role of NLRP3, NLRP10, AIM2, TLR9, and PANoptosis.

Handbook of experimental pharmacology·2026
Same author

Adipose Triglyceride Lipase and Gpr40 Contribute to the Anti-Contractile Effect of Perivascular Adipose Tissue.

Microcirculation (New York, N.Y. : 1994)·2026
Same author

Erectile and Clitoral Dysfunction as Harbingers of Cardiovascular Disease: A Perspective.

Medicina (Kaunas, Lithuania)·2026
Same author

Sex-specific vascular effects of menthol: TRPM8- and TRPA1-dependent relaxation in female mouse aorta and pudendal arteries.

Canadian journal of physiology and pharmacology·2026
Same author

Toxicological evaluation of entricitabine and tenofovir disoproxyl fumarate, isolated and mixture, in cyanobacteria and microalgae.

The Science of the total environment·2025

Related Experiment Video

Updated: May 25, 2026

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

New insights into hypertension-associated erectile dysfunction.

Kenia Pedrosa Nunes1, Hicham Labazi, R Clinton Webb

  • 1Department of Physiology, Georgia Health Sciences University, Georgia, Augusta, USA.

Current Opinion in Nephrology and Hypertension
|January 14, 2012
PubMed
Summary

Erectile dysfunction (ED) and hypertension share common mechanisms, particularly endothelial dysfunction. ED may be an early indicator of hypertension, and understanding their relationship can reveal new therapeutic targets.

Related Experiment Videos

Last Updated: May 25, 2026

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

Area of Science:

  • Cardiovascular Medicine
  • Urology
  • Pharmacology

Background:

  • Erectile dysfunction (ED) is a quality-of-life disorder affecting millions, with 30% of hypertensive patients reporting symptoms.
  • Hypertension and ED are closely linked, sharing endothelial dysfunction as a common pathophysiological basis.

Purpose of the Study:

  • To explore the intricate relationship between hypertension and ED.
  • To investigate the impact of antihypertensive medications on ED.
  • To identify novel therapeutic targets for improving patient quality of life.

Main Methods:

  • Literature review of current research on hypertension and ED.
  • Analysis of the common mechanisms underlying both conditions.
  • Examination of the effects of antihypertensive drugs on ED.

Main Results:

  • Endothelial dysfunction is a key shared mechanism, leading to vascular smooth muscle contraction.
  • Hypertension can cause ED directly or as a side effect of treatment; ED may also precede hypertension.
  • Phosphodiesterase-5 inhibitors show potential in improving blood pressure, but the full link is unclear.

Conclusions:

  • The interplay between hypertension and ED is complex and warrants further investigation.
  • Understanding these connections can lead to improved management strategies for both conditions.
  • New therapeutic avenues may emerge from studying hypertension-associated ED and drug effects.